Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
0.8400
+0.0516 (6.54%)
Nov 6, 2026, 4:00 PM EST - Market closed
Perspective Therapeutics Stock Forecast
CATX's stock price has decreased by -63.95% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 16 analysts polled by S&P Global, Perspective Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $10.57. The average 1-year stock price forecast is 1,158.33% higher than the current stock price, while the lowest is $4.00 (+376.19%) and the highest is $15 (+1,685.71%).
Price Target: $10.57 (+1,158.33%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 13 | 13 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $18 → $6 | Buy | Reiterates | $18 → $6 | +614.29% | Oct 28, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $5 | Hold | Maintains | $5 | +495.24% | Oct 26, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades $14 → $4 | Hold | Downgrades | $14 → $4 | +376.19% | Oct 26, 2026 |
| BTIG | BTIG | Buy Maintains $14 | Buy | Maintains | $14 | +1,566.67% | Oct 26, 2026 |
| UBS | UBS | Buy Maintains $8 | Buy | Maintains | $8 | +852.38% | Oct 23, 2026 |
Financial Forecast
Revenue This Year
299.00K
from 884.00K
Decreased by -66.18%
Revenue Next Year
314.55K
from 299.00K
Increased by 5.20%
EPS This Year
-0.99
from -1.40
EPS Next Year
-1.03
from -0.99
EPS and Forward PE are based on non-GAAP adjusted numbers.